AnthropicEventHealthOctober 27, 2026

Anthropic details early drug development work with Claude

Read original source →anthropic.com

Anthropic says its scientists have partnered with six drug developers — BigHat Biosciences, Bristol Myers Squibb, Divergence Labs, Enveda, Generate Biomedicines and The Column Group — and started its own discovery programs, including for rare childhood muscular dystrophies. Its IPO filing concedes the company needs "first-hand experience" in lab work and regulation.

People · Dario Amodei

3 sources

More stories today

Open the live feed